The Prescription Drug Transparency and Affordability Council, established in HB 166, is tasked with providing recommendations to the General Assembly, Governor DeWine, and the Joint Medicaid Oversight Committee regarding Ohio's best path forward for issues such as prescription drug price transparency, affordable payment models, and health care efficiency.
- Matt Damschroder, Director, Ohio Department of Administrative Services
- Director, Ohio Department of Health
- Maureen Corcoran, Director, Ohio Department of Medicaid
- Lori Criss, Director, Ohio Department of Mental Health and Addiction Services
- Stephanie McCloud, Administrator, Ohio Bureau of Workers’ Compensation
- Steve Ferris, Discount Drug Mart
- Ryan Augsburger, Ohio Manufacturers’ Association
- Holly L. Pendell, National Multiple Sclerosis Society
- James Flynn, Managing Partner, Bricker & Eckler
- Latoya Peterson, Associate State Director for Advocacy, AARP
- Mark Totman, Vice President, International Union of Operating Engineers
- The Honorable Christina Muryn, Mayor of Findlay, Ohio
- Pat Tiberi, President and CEO, Ohio Business Roundtable
- Wednesday, Feb. 26, 2020: Welcome and general overview
- Wednesday, May 27, 2020: Virtual meeting from 11 a.m. to noon
- Monday, June 15, 2020: Virtual meeting from 11 a.m. to noon.
- Wednesday, July 8, 2020: Virtual meeting from 10 to 11 a.m.
- Wednesday, Aug. 19, 2020: Virtual meeting at 10 a.m.
- Wednesday, Aug. 26, 2020: Virtual meeting at 10 a.m.
- Monday, Nov. 23, 2020: Virtual meeting at noon.
To subscribe to receive notices regarding the meetings, email Mariah Halleck at Mariah.Halleck@das.ohio.gov.